Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population".

Journal Article (Letter)

The authors of the manuscript "Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population" respond to a letter to the editor.

Full Text

Duke Authors

Cited Authors

  • Wittbrodt, ET; Eudicone, JM; Bell, KF; Enhoffer, DM; Latham, K; Green, JB

Published Date

  • April 2019

Published In

Volume / Issue

  • 25 / 4

Start / End Page

  • 171 - 172

PubMed ID

  • 30986013

Pubmed Central ID

  • 30986013

Electronic International Standard Serial Number (EISSN)

  • 1936-2692

Language

  • eng

Conference Location

  • United States